ANTIBODIES THAT SPECIFICALLY BIND TO TL1A

Recombinantly expressed variant antibodies that have enhanced affinity for TL1A and enhanced potency relative to the parent antibody from which they were derived are provided. The antibodies inhibit the interaction between TL1A and the death receptor 3 (DR3). The antibodies, or a composition thereof...

Full description

Saved in:
Bibliographic Details
Main Authors POLLARD Matthew, COOKSEY Bridget Ann, PANDE Vanya, DOYLE Anthony G, POULTON Lynn Dorothy, CLARKE Adam William
Format Patent
LanguageEnglish
Slovenian
Published 30.10.2020
Subjects
Online AccessGet full text

Cover

Loading…